Skip to main content
. 2013 Aug;23(8):947–954. doi: 10.1089/thy.2012.0471

Table 1.

Descriptives for the Study Population (n=2078)

Variable Women (n=1013) Men (n=1065)
General characteristics
Age (years) 45 [40–50] 46 [41–51]
Height (cm) 163±6 176±7
Weight (kg) 65.4±11.6 81.1±12.2
BMI (kg/m2) 24.5±4.2 26.2±3.6
Smoking (active/ex/never; %) 19/21/60 22/36/42
TSH and thyroid hormones
TSH (mU/L) 1.54 [1.08–2.08] 1.47 [1.03–2.04]
FT4 (ng/dL) 1.25 [1.15–1.35] 1.34 [1.23–1.44]
FT3 (pg/mL) 3.0 [2.8–3.2] 3.4 [3.1–3.6]
TT3 (ng/dL) 120 [105–140] 118 [107–129]
Blood pressure and heart rate
Systolic BP (mm Hg) 121±13 130±12
Diastolic BP (mm Hg) 77±9 82±9
Heart rate (average; bpm) 68±9 64±10
Echocardiographic parameters
Systolic function
 Ejection fraction (%) 67±8 65±8
 s′ (mm/s) 80±11 79±12
 LVESD (mm) 28±4 32±4
Diastolic function
 E (cm/s) 79±14 71±13
 A (cm/s) 62±11 59±10
 e′ (mm/s) 96±21 87±18
 a′ (mm/s) 86±15 92±15
LV structure
 LV mass (g) 121±29 177±39
 LVMI (g/m2) 71±14 90±18
 LVEDD (mm) 45±4 49±4
 Relative wall thickness 0.36±0.06 0.39±0.07

Subjects on thyroid or antihypertensive medication, with antithyroperoxidase antibodies above clinical cut-off, and with TSH levels outside the reference range were excluded from further analyses. Data are mean±SD or medians [first, third quartile] in case of non-Gaussian distribution. Conversion factor for FT3 from pg/mL to pmol/L and for TT3 from ng/dL to nmol/L is ×0.0154; conversion factor for FT4 from ng/dL to pmol/L is ×12.87.

T3, triiodothyronine; TSH, thyrotropin; FT4, free thyroxine; FT3, free T3; TT3, total T3; LVESD, left ventricular end-systolic diameter; s′, systolic mitral annulus velocity; E, early diastolic transmitral flow velocity; A, late diastolic transmitral flow velocity; e′, pulsed-wave tissue Doppler early diastolic component; a′, pulsed-wave tissue Doppler late diastolic component; LVMI, left ventricular mass index; LVEDD, left ventricular end-diastolic diameter.